Skip to main content
PMC home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1992 Jul;34(4):265–271. doi: 10.1007/BF01741795

Effect of monoclonal antibodies to early pregnancy factor (EPF) on the in vivo growth of transplantable murine tumours

K A Quinn 1, H Morton 1,✉
PMCID: PMC11038521  PMID: 1537058

Abstract

Neutralisation studies with monoclonal antibodies (mAbs) specific for early pregnancy factor (EPF) have shown it to be essential for the continuation of pregnancy in mice and the growth of some tumour cells in vitro. These studies report that the mAbs are also able to limit the growth of two murine tumour lines transplanted s. c. The development of MCA-2 tumours in CBA mice was unaffected by the injection of 1 mg anti-EPF IgM at the time of tumour cell inoculation. However, four doses of 500 µg anti-EPF, injected one dose per day for 4 days after tumour cell inoculation, significantly retarded tumour development such that no tumours were palpable on day 13. A similar dose regimen of control IgM had no effect on tumour size. Dose/response studies revealed that lower doses of anti-EPF administered after tumour cell inoculation were effective in retarding the growth of the MCA-2 tumours. The effect of anti-EPF mAb administration on the growth rate of palpable B16 tumours established s. c. in C57BL/6 mice was also determined. Tumours injected with 6 mg anti-EPF 5/341 or anti-EPF 5/333 mAbs showed significant decrease in the uptake of [3H]thymidine into tumour tissue, measured 16 h after injection. Furthermore, titration of sera for active EPF showed that a significant reduction in the EPF titre was associated with a significant inhibition of tumour DNA synthesis. Thus it appears that neutralisation of EPF retards tumour growth both in vitro and in vivo. In vitro the effects must be due to anti-EPF mAb interfering with a direct mechanism that contributes to the maintenance of cells in the active growing phase. However, in vivo host immunological mechanism that are modified to allow tumour survival may also be affected. The presence of EPF-induced suppressor factors curculating in the serum of tumour-bearing mice has been confirmed and the contribution of such factors to tumour progression must now be investigated.

Key words: Early pregnancy factor, EPF, Monoclonal antibodies, Tumour retardation

References

  • 1.Athanasas-Platsis S, Quinn KA, Wong TY, Rolfe BE, Cavanagh AC, Morton H. Passive immunization of pregnant mice against early pregnancy factor causes loss of embryonic viability. J Reprod Fertil. 1989;87:495. doi: 10.1530/jrf.0.0870495. [DOI] [PubMed] [Google Scholar]
  • 2.Athanasas-Platsis S, Morton H, Dunglison GF, Kaye PL. Antibodies to early pregnancy factor retard embryonic development in vivo in mice. J Reprod Fertil. 1991;92:443. doi: 10.1530/jrf.0.0920443. [DOI] [PubMed] [Google Scholar]
  • 3.Bach JF, Dormont J, Dardenne M, Balner H. In vitro rosette inhibition by anti-human ALS. Transplantation. 1969;8:265. doi: 10.1097/00007890-196909000-00008. [DOI] [PubMed] [Google Scholar]
  • 4.Burton K. Studies of conditions and mechanisms of diphenylamine reaction for colorimetric estimation of deoxyribonucleic acid. Biochem J. 1956;62:315. doi: 10.1042/bj0620315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Cavanagh AC. Production in vitro of mouse pregnancy factor and purification to homogeneity. J Reprod Fertil. 1984;71:581. doi: 10.1530/jrf.0.0710581. [DOI] [PubMed] [Google Scholar]
  • 6.Cavanagh AC, Morton H, Athanasas-Platsis S, Quinn KA, Rolfe BE. Identification of a putative inhibitor of early pregnancy factor in mice. J Reprod Fertil. 1991;91:239. doi: 10.1530/jrf.0.0910239. [DOI] [PubMed] [Google Scholar]
  • 7.Cavanagh AC, Rolfe BE, Athanasas-Platsis S, Quinn KA, Morton H. Relationship of early pregnancy factor, mouse embryo-conditioned medium and platelet activating factor. J Reprod Fertil. 1991;93:355. doi: 10.1530/jrf.0.0930355. [DOI] [PubMed] [Google Scholar]
  • 8.Fidler IJ. Metastasis: quantitative analysis of distribution and fate of tumour emboli labelled with125 I-5-iodo-deoxyurdine. JNCI. 1970;45:773. [PubMed] [Google Scholar]
  • 9.Haranaka K, Satomi N, Sakurai A. Anti-tumour activity of murine tumour necrosis factor (TNF) against transplanted tumours and heterotransplanted human tumours in nude mice. Int J Cancer. 1984;34:263. doi: 10.1002/ijc.2910340219. [DOI] [PubMed] [Google Scholar]
  • 10.Haubeck HD, Kolsch E. Isolation and characterisation of in vitro and in vivo functions of a tumour-specific T suppressor cell clone from a BALB/c mouse bearing the syngeneic ADJ-PC-5 plasmacytoma. J Immunol. 1985;135:4297. [PubMed] [Google Scholar]
  • 11.Koppi TA, Halliday WJ. Cellular origin of blocking factors from cultured spleen cells of tumour bearing mice. Cell Immunol. 1983;76:29. doi: 10.1016/0008-8749(83)90345-3. [DOI] [PubMed] [Google Scholar]
  • 12.Morton H, Hegh V, Clunie GJA. Studies of the rosette inhibition test in pregnant mice: evidence of immunosuppression? Proc R Soc Lond [Biol] 1976;193:413. doi: 10.1098/rspb.1976.0054. [DOI] [PubMed] [Google Scholar]
  • 13.Morton H, Rolfe BE, Cavanagh AC. Ovum factor and early pregnancy factor. Curr Top Dev Biol. 1987;23:73. doi: 10.1016/s0070-2153(08)60620-1. [DOI] [PubMed] [Google Scholar]
  • 14.Noonan FP, Halliday WJ, Morton H, Clunie GJA. Early pregnancy factor is immunosuppresive. Nature. 1979;278:649. doi: 10.1038/278649a0. [DOI] [PubMed] [Google Scholar]
  • 15.Osieka R, Houchens DP, Goldin A, Johnson RK. Chemotherapy of human colon cancer zenographs in athymic nude mice. Cancer. 1977;40:2640. doi: 10.1002/1097-0142(197711)40:5+<2640::aid-cncr2820400938>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  • 16.Quinn KA (1991) Early pregnancy factor: a novel factor involved in cellular proliferation. PhD Thesis, University of Queensland
  • 17.Quinn KA, Athanasas-Platsis S, Wong TY, Rolfe BE, Cavanagh AC, Morton H. Monoclonal antibodies to early pregnancy factor perturb tumour cell growth. Clin Exp Immunol. 1990;80:100. doi: 10.1111/j.1365-2249.1990.tb06448.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Roitt IM. Essential immunology. 4th ed. Oxford: Blackwell Scientific; 1980. p. 42. [Google Scholar]
  • 19.Rolfe BE, Morton H, Cavanagh AC, Gardiner RA. Detection of an early pregnancy factor-like substance in sera of patients with testicular germ-cell tumours. Am J Reprod Immunol. 1983;3:97. doi: 10.1111/j.1600-0897.1983.tb00223.x. [DOI] [PubMed] [Google Scholar]
  • 20.Rolfe B, Cavanagh A, Forde C, Basten F, Chen C, Morton H. Modified rosette inhibition test with mouse lymphocytes for detection of early pregnancy factor in human pregnancy serum. J Immunol Methods. 1984;70:1. doi: 10.1016/0022-1759(84)90383-1. [DOI] [PubMed] [Google Scholar]
  • 21.Rolfe BE, Cavanagh AC, Quinn KA, Morton H. Identification of two suppressor factors induced by early pregnancy factor. Clin Exp Immunol. 1988;73:219. [PMC free article] [PubMed] [Google Scholar]
  • 22.Rolfe B, Quinn K, Athanasas S, Cavanagh A, Morton H. Genetically restricted effector molecule released by human lymphocytes in response to early pregnancy factor. Immunol Cell Biol. 1989;67:205. doi: 10.1038/icb.1989.31. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES